AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision tool Vrije Universiteit Brussel
BACKGROUND & AIMS: Two recently developed composite models, the alpha-fetoprotein (AFP) score and Metroticket 2.0, could be used to select patients with hepatocellular carcinoma (HCC) who are candidates for liver transplantation (LT). The aim of this study was to compare the predictive performance of both models and to evaluate the net risk reclassification of post-LT recurrence between them using each model's original thresholds.
...